EUVIMEDEUVIMED entdecken
Vergleichsstudie

Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children

Kenta Sugiura iD, Yusuke Hagiwara iD, Osamu Nomura iD, Yoshihiko Morikawa iD, Hiroshi Hataya iD, Koichi Yoshida iD

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70072 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatrics International, online erschienen am 14.05.2025. Verfasst von Kenta Sugiura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Emergency Medicine, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan. Hauptthemen laut MEDLINE: Asthma, Metered Dose Inhalers, Procaterol, Nebulizers and Vaporizers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To date, no studies have assessed the outcomes of different inhalation methods for procaterol, a short‐acting β2‐agonist frequently used in Japan to treat acute asthma exacerbations in children. The present study compared the efficacy and safety of procaterol using a nebulizer (NEB) and a metered‐dose inhaler (MDI) with a spacer.

Methods

The present before‐and‐after study targeted patients aged 4–16 years with moderate to severe acute asthma exacerbations who visited the pediatric emergency department (PED). The primary outcome was a reduction in the Modified Pulmonary Index Score (MPIS), and the secondary outcomes were the hospitalization rate, length of stay (LOS), and incidence of adverse events. Propensity score matching and multiple regression analysis were conducted to adjust for confounding factors.

Results

Forty‐nine patients were selected from 70 and 77 patients in the NEB and MDI group, respectively, using propensity score matching. No statistically significant difference in MPIS reduction (3.7 vs. 4.3; p = 0.13) or the hospitalization rate (26.5% vs. 20.4%; p = 0.48) was found between the groups. The LOS (94 vs. 61 min; p < 0.001) was significantly shorter in the MDI group. Only one patient (2.0%) using an MDI experienced vomiting.

Conclusions

An MDI with a spacer was comparable to an NEB in effectiveness and was associated with a shorter LOS and lower incidence of adverse events. An MDI with a spacer may serve as an alternative to an NEB for administering inhaled procaterol in patients with acute asthma exacerbation in the PED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetered Dose InhalersProcaterolNebulizers and VaporizersAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsHumansChildMaleFemaleAdolescentChild, PreschoolAdministration, InhalationTreatment OutcomeRetrospective StudiesHospitalizationAcute DiseaseInhalation SpacersLength of StayJapanPropensity Score

Stichwörter der Autor:innen

asthmachildinhalation spacersmetered‐dose inhalersprocaterol

Substanzen

ProcaterolAdrenergic beta-2 Receptor AgonistsBronchodilator Agents

Autor:innen und Institutionen

  • Division of Pediatric Emergency Medicine, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
  • Medical Education Development Center, Gifu University, Gifu, Gifu, Japan.
  • Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
  • Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.
  • Division of Allergy, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.

ORCID-Profile: Kenta Sugiura, Yusuke Hagiwara, Osamu Nomura, Yoshihiko Morikawa, Hiroshi Hataya, Koichi Yoshida

Zitieren

APA

Sugiura, K., Hagiwara, Y., Nomura, O., Morikawa, Y., Hataya, H., & Yoshida, K. (2025). Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70072

Vancouver

Sugiura K, Hagiwara Y, Nomura O, Morikawa Y, Hataya H, Yoshida K. Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children. Pediatrics International. 2025;67(1). doi:10.1111/ped.70072

BibTeX
@article{Sugiura2025,
  author = {Sugiura, Kenta and Hagiwara, Yusuke and Nomura, Osamu and Morikawa, Yoshihiko and Hataya, Hiroshi and Yoshida, Koichi},
  title = {Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70072}
}
Kostenlos starten →